IRIS
OYEN, Willem Jozef Gerard
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.744
EU - Europa 4.470
AS - Asia 2.357
AF - Africa 916
OC - Oceania 45
SA - Sud America 28
Continente sconosciuto - Info sul continente non disponibili 14
Totale 41.574
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.520
SG - Singapore 1.606
FI - Finlandia 1.358
IE - Irlanda 1.053
NG - Nigeria 912
FR - Francia 562
CN - Cina 433
DE - Germania 429
NL - Olanda 382
GB - Regno Unito 239
CA - Canada 219
IT - Italia 199
TR - Turchia 110
IL - Israele 91
SE - Svezia 73
IN - India 48
RU - Federazione Russa 48
AU - Australia 33
IR - Iran 26
CL - Cile 19
CZ - Repubblica Ceca 18
ES - Italia 14
UA - Ucraina 14
A2 - ???statistics.table.value.countryCode.A2??? 13
JP - Giappone 13
NZ - Nuova Zelanda 12
RO - Romania 11
HK - Hong Kong 10
PL - Polonia 10
GR - Grecia 8
AT - Austria 7
BE - Belgio 7
CH - Svizzera 6
DK - Danimarca 6
MD - Moldavia 6
NO - Norvegia 5
CO - Colombia 4
MX - Messico 4
AE - Emirati Arabi Uniti 3
BR - Brasile 3
MY - Malesia 3
BD - Bangladesh 2
BG - Bulgaria 2
EG - Egitto 2
LI - Liechtenstein 2
LK - Sri Lanka 2
PH - Filippine 2
PT - Portogallo 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
IM - Isola di Man 1
IQ - Iraq 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MN - Mongolia 1
MT - Malta 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
SA - Arabia Saudita 1
TH - Thailandia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 41.574
Salva come PNG Salva come JPEG
Città #
Chandler 7.384
Wilmington 6.844
San Mateo 2.585
Ann Arbor 1.399
Helsinki 1.358
Leawood 1.221
Lawrence 1.117
Princeton 1.117
Dublin 1.048
Singapore 1.048
Boardman 1.005
Benin City 911
Fairfield 682
Woodbridge 641
New York 563
Paris 553
Ashburn 417
Shanghai 409
Amsterdam 372
Seattle 348
San Diego 312
London 212
Toronto 196
Norwalk 128
Kocaeli 103
Milan 98
Falkenstein 53
Los Angeles 53
Santa Clara 39
Phoenix 38
Pune 35
Houston 31
Monmouth Junction 30
Moscow 29
Redmond 28
Des Moines 26
Clearwater 14
Hanover 13
Andover 12
Cambridge 12
Redwood City 12
Abbiategrasso 11
Brno 11
Munich 10
Barletta 7
Frankfurt am Main 7
Las Vegas 7
Auckland 6
Brussels 6
Chisinau 6
Hangzhou 6
Istanbul 6
Kemerovo 6
Olomouc 6
Sydney 6
Saint Paul 5
Tokyo 5
Athens 4
Augusta 4
Berlin 4
Chicago 4
Jacksonville 4
Laval 4
Melbourne 4
Nanjing 4
Sacramento 4
Saint Louis 4
Trapani 4
Winnipeg 4
Birmingham 3
Central 3
Collegeville 3
Columbus 3
Cupertino 3
Eden Prairie 3
Hamilton 3
Houilles 3
Newark 3
Perth 3
Staten Island 3
Stockholm 3
São Luís 3
Tappahannock 3
Tortona 3
Vancouver 3
Adelaide 2
Apo 2
Beaverton 2
Belfast 2
Belgrade 2
Bintulu 2
Blythewood 2
Bogotá 2
Buffalo 2
Camponaraya 2
Chengdu 2
Cheyenne 2
Christchurch 2
Cinisello Balsamo 2
Copenhagen 2
Totale 32.733
Salva come PNG Salva come JPEG
Nome #
18-F fluorodeoxygenase (FDG) positron emission tomography (PET) scanning prior to radical lung radiotherapy. A retrospective audit of practice 76
(18)FDG-PET for staging (non)seminomatous germ cell tumours [(N)SGCT] and for evaluation of postchemotherapy residual masses. 73
Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients 69
PET-CT for response assessment and treatment adaptation in head and neck cancer 66
New targeted probes for radioimaging of angiogenesis 64
The Role of FDG-PET in the Assessment of Thyroid Nodules with an Indeterminant or Suspicious Cytologic Diagnosis 64
Guideline for PET/CT imaging of neuroendocrine neoplasms with Ga-68-DOTA-conjugated somatostatin receptor targeting peptides and F-18-DOPA 63
2-(F-18)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: A prospective study 63
F-18-FDG PET/CT for the Detection of Septic Embolisms in Patients with Infectious Endocarditis 63
Abscopal effect of radiotherapy in a patient with metastatic diffuse-type giant cell tumor 62
Effect of the positron range on the spatial resolution of a new generation pre-clinical PET using fluorine-18, gallium-68, zirconium-89 and iodine-124 62
A direct comparison of four different Ga-68-labeled RGD peptides for PET/CT imaging of angiogenesis 61
F-18-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation 61
Radioimmunotherapy with I-131-cG250 monoclonal antibody in patients with metastasized RCC, a phase I/II study. 60
18F-FLT-PET for the evaluation of MEK inhibitor AZD6244 59
Kidney protection during peptide receptor radionuclide therapy (PRRT) 59
F-18-FLT PET changes during radiotherapy combined with cetuximab in head and neck squamous cell carcinoma patients 59
F-18-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality 59
F-18-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis 58
Update on F-18-fluoro-deoxy-glucose-PET/computed tomography in nonsmall cell lung cancer 58
Albumin derived peptides efficiently reduce renal uptake of radiolabeled peptides 58
[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer 58
F-18-FDG PET of thyroid nodules with inconclusive cytologic results - Reply 57
Background-subtracted optimal threshold segmentation algorithm for FDG-PET based GTV delineation: Theory and experimental validation 57
F-18-FDG PET AS A PREDICTOR OF PULMONARY FUNCTION IN SARCOIDOSIS 57
Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer 56
Improved selection of patients for hepatic surgery of colorectal liver metastases with FDG-PET: A randomized study 56
Pulmonary sclerosing hemangioma detected by fluorodeoxyglucose positron emission tomography in familial adenomatous polyposis: Report of a case 56
F-18-FDG PET patterns and BAL cell profiles in pulmonary sarcoidosis 56
[F-18]FDG accumulation in an experimental model of multistage progression of cholangiocarcinoma 56
INTERIM ANALYSIS OF A PHASE I RADIOIMMUNOTHERAPY STUDY IN ADVANCED RENAL CELL CARCINOMA PATIENTS USING LUTETIUM-177 LABELED MONOCLONAL ANTIBODY CG250 55
CAN FOG-PET PREDICT RADIATION TREATMENT OUTCOME IN HEAD AND NECK CANCER? 55
Clinical application of FDG-PET/CT in metastatic infections 55
A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER 55
A bivalent leukotriene B-4 antagonist for scintigraphic Imaging of infectious foci 55
The role of megalin in the renal uptake of radiolabeled peptides 54
Reducing renal uptake of radiolabeled peptides using albumin fragments 54
SORAFENIB REDUCES UPTAKE OF 111-INDIUM LABELED BEVACIZUMAB IN CLEAR CELL RENAL CELL CARCINOMA 54
Progress in nuclear medicine procedures in head and neck oncology 54
99mTc-interleukin-8 for imaging acute osteomyelitis 54
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer 54
PET and SPECT Imaging of a Radio labeled Minigastrin Analogue Conjugated with DOTA, NOTA, and NODAGA and Labeled with Cu-64, Ga-68, and In-111 54
Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise 53
Molecular imaging of hypoxia 53
Molecular Imaging and Theranostics-A Multidisciplinary Approach 53
EANM Focus 1: one small step for two men, one giant leap for a specialty 53
Comparison of liver SUV using unenhanced CT versus contrast- enhanced CT for attenuation correction in 18 F-FDGPET/CT 53
LOCALIZATION OF INFECTION IN HIV ANTIBODY-POSITIVE PATIENTS WITH FEVER - COMPARISON OF THE EFFICACY OF GA-67-CITRATE AND RADIOLABELED HUMAN-IGG 53
Macrophage targeting in experimental arthritis 53
A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using Ga-68-RGD PET/CT 53
F-18-FDG-PET/CT as a diagnostic tool in native valve endocarditis 53
RADIOIMMUNOCONJUGATES IN THE DETECTION OF INFECTION AND INFLAMMATION 53
A modelling approach to estimate the FDG arterial plasma time activity curve in Patlak-based therapy response analysis 52
IMPROVED SELECTION OF PATIENTS FOR HEPATIC SURGERY OF COLORECTAL LIVER METASTASES WITH FDG-PET: RESULTS OF THE RANDOMIZED DUTCH POLEM STUDY 52
Tumor-Receptor Imaging in Breast Cancer: A Tool for Patient Selection and Response Monitoring 52
Pretargeted immuno-PET imaging and radioimmunotherapy of prostate cancer with an anti-EGP1 x anti-HSG bispecific antibody 52
Evaluation of the advanced ReSPECT image reconstruction software in a phantom model and in parathyroid scanning 52
Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring F-18-FDG PET studies 52
Radiolabeled IL-1ra for detection of synovitis in patients with RA. Preliminary results. 52
Phase 1 Radioimmunotherapy Study with Lutetium 177-labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma 52
FDG-PET in diagnosing central venous catheter related infection in stem cell transplant recipients 52
Tc-99m-CXCL8 SPECT to Monitor Disease Activity in Inflammatory Bowel Disease 52
Pharmacokinetics and tumor targeting of I-131-labeled F(ab ')(2) fragments of the chimeric monoclonal antibody G250: Preclinical and clinical pilot studies 52
F-18-FDG PET in detecting metastatic infectious disease 52
[F-18]fluoro-2-deoxy-d-glucose positron emission tomography detects gastric carcinoma in an early stage in an asymptomatic e-cadherin mutation carrier 52
F-18-fluorodeoxyglucose positron emission tomography combined with CT in critically ill patients with suspected infection 52
SPECT/CT-based Dosimetry for a Multicentre Trial of Selumetinib Enhanced Radioiodine Treatment of Differentiated Thyroid Cancer: Preliminary Results 51
Amplitude-based optimal respiratory gating in positron emission tomography in patients with primary lung cancer 51
Aberrant reward processing in Parkinson's disease is associated with dopamine cell loss 51
18F-FDG PET/CT in Detecting Metastatic Infection in Children 51
FDG-PET and CT in the staging of melanoma patients with lymph node metastases; diagnostic performance and clinical consequences 51
Absorption and biodistribution of (111)indium-labelled desferrioxamine (In-111-DFO) after subcutaneous injection of In-111-DFO liposomes 51
Liposomes for scintigraphic imaging: Optimization of in vivo behavior 51
Scintigraphic evaluation of experimental chronic osteomyelitis. 51
Imaging of inflamed joints in patients with active rheumatoid arthritis with radiolabeled interleukin-1 receptor antagonist. Initial results. 51
Tracers to monitor the response to chemotherapy: In vitro screening of four radiopharmaceuticals 51
Development of In-111-labeled tumor-associated antigen peptides for monitoring dendritic-cell-based vaccination 51
Imaging of Prostate Cancer with Immuno-PET and Immuno-SPECT Using a Radiolabeled Anti-EGP-1 Monoclonal Antibody 51
WHICH FACTORS PREDICT THE RESULTS OF PITUITARY SURGERY IN ACROMEGALY 51
The EANM practical guidelines for sentinel lymph node localisation in oral cavity squamous cell carcinoma 51
Lesion detection by [Zr-89]Zr-DFO-girentuximab and [F-18]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma 50
F-18-FLT PET/CT for Early Response Monitoring and Dose Escalation in Oropharyngeal Tumors 50
SPECIFIC ANTIBODY UPTAKE IN TUBERCULOSIS 50
INDIUM-111-LABELED HUMAN NONSPECIFIC IMMUNOGLOBULIN-G - A NEW RADIOPHARMACEUTICAL FOR IMAGING INFECTIOUS AND INFLAMMATORY FOCI 50
F-18-FDG PET/CT in Local Ablative Therapies: A Systematic Review 50
PET/CT imaging of angiogenesis in head and neck squamous cell carcinoma patients 50
Authors' reply: Value of fluorodeoxyglucose positron emission tomography in women with breast cancer 50
Radiopharmaceuticals to image infection and inflammation 50
Using dynamic F-18-FDG PET for lung tumour segmentation and quantitative assessment of glucose metabolism for different histological types 50
Referred shoulder pain in a patient with small cell lung cancer 50
Dose escalation of Re-186-labeled humanized monoclonal antibody LL2 in patients with non-Hodgkin's lymphoma (NHL). 50
Comparison of potential of interleukin-1, its receptor antagonist and a chemotactic peptide for imaging of infection. 50
Inhibition of kidney uptake of radiolabeled somatostatin analogs: Amino acids or Gelofusine? Reply 50
Targeting CCK2R-expressing tumors with twelve CCK/gastrin analogs in mice with CCK2R+tumors 50
Megalin Plays an Important Role in the Renal Uptake of Various Radiolabeled Peptides: Studies in Megalin-Deficient Mice 50
A COMPARISON OF IN-111-HIG SCINTIGRAPHY AND CHEST RADIOLOGY IN THE IDENTIFICATION OF PULMONARY INFECTION IN PATIENTS WITH HIV-INFECTION 50
Radiation Exposure (Un)Awareness amongst nuclear medicine patients - a systematic review 50
Quantitative Assessment of Heterogeneity in Tumor Metabolism Using FDG-PET 49
Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT 49
Radioimmunotherapy Prevents Anastomotic Relapse of Colorectal Cancer in a Rat Model 49
Totale 5.448
Salva come PNG Salva come JPEG
Categoria #
all - tutte 337.809
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 337.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 0 0 0 0 0 0 0 80
2020/202112.072 13 14 35 19 43 3.751 1.701 567 2.520 2.209 3 1.197
2021/20224.624 79 16 98 1.388 3 6 125 845 434 328 1.014 288
2022/202317.894 2.482 630 1.667 1.829 1.924 1.631 9 1.746 3.327 1.394 999 256
2023/20246.742 649 910 1.757 184 209 609 136 381 90 69 488 1.260
2024/2025338 186 152 0 0 0 0 0 0 0 0 0 0
Totale 41.750